DK4396183T3 - Substituerede s-alaninatderivater - Google Patents

Substituerede s-alaninatderivater

Info

Publication number
DK4396183T3
DK4396183T3 DK22769666.3T DK22769666T DK4396183T3 DK 4396183 T3 DK4396183 T3 DK 4396183T3 DK 22769666 T DK22769666 T DK 22769666T DK 4396183 T3 DK4396183 T3 DK 4396183T3
Authority
DK
Denmark
Prior art keywords
alaninate
derivatives
substituted
alaninate derivatives
Prior art date
Application number
DK22769666.3T
Other languages
English (en)
Inventor
Hartmut Beck
Stefanie Mesch
Alexandros Vakalopoulos
Nils Pfaff
Stefanie Zimmermann
Markus Follmann
Elisabeth Kersten
Guillaume Levilain
Katrin Partikel
Andreas Peter Broehl
Stefan Heitmeier
Julia Dietze-Torres
Lutz Lehmann
Kersten Matthias Gericke
Frank Süssmeier
Lars Bärfacker
Alexander Hillisch
Adrian Tersteegen
Anja Buchmüller
Christoph Gerdes
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK4396183T3 publication Critical patent/DK4396183T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK22769666.3T 2021-09-03 2022-08-29 Substituerede s-alaninatderivater DK4396183T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21194781 2021-09-03
PCT/EP2022/073889 WO2023031083A1 (en) 2021-09-03 2022-08-29 Substituted s-alaninate derivatives

Publications (1)

Publication Number Publication Date
DK4396183T3 true DK4396183T3 (da) 2025-11-17

Family

ID=77640441

Family Applications (1)

Application Number Title Priority Date Filing Date
DK22769666.3T DK4396183T3 (da) 2021-09-03 2022-08-29 Substituerede s-alaninatderivater

Country Status (31)

Country Link
US (2) US20250002483A1 (da)
EP (1) EP4396183B1 (da)
JP (1) JP7546172B2 (da)
KR (1) KR20240055043A (da)
CN (1) CN117916236A (da)
AR (1) AR126980A1 (da)
AU (1) AU2022338082A1 (da)
CA (1) CA3230721A1 (da)
CL (1) CL2024000638A1 (da)
CO (1) CO2024002668A2 (da)
CR (1) CR20240114A (da)
DK (1) DK4396183T3 (da)
DO (1) DOP2024000024A (da)
EC (1) ECSP24024658A (da)
ES (1) ES3055022T3 (da)
FI (1) FI4396183T3 (da)
GE (2) GEP20257776B (da)
HR (1) HRP20251414T1 (da)
IL (1) IL310777A (da)
JO (1) JOP20240043A1 (da)
LT (1) LT4396183T (da)
MA (1) MA66371B1 (da)
MX (1) MX2024002750A (da)
PE (1) PE20240798A1 (da)
PL (1) PL4396183T3 (da)
PT (1) PT4396183T (da)
RS (1) RS67431B1 (da)
SI (1) SI4396183T1 (da)
TW (1) TW202320754A (da)
WO (1) WO2023031083A1 (da)
ZA (1) ZA202402553B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024175450A1 (en) * 2023-02-21 2024-08-29 Bayer Aktiengesellschaft Substituted s-alaninate derivatives
WO2025237307A1 (zh) * 2024-05-14 2025-11-20 苏州康宁杰瑞生物科技有限公司 凝血因子FXI/FXIa抑制剂用于治疗肺动脉高压和/或高血压
CN119366487A (zh) * 2024-10-30 2025-01-28 健帆生物科技集团股份有限公司 一种用于血液灌流器对内毒素吸附性能的评价方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0042675A1 (en) 1980-06-20 1981-12-30 Norton Company Method of mounting a grinding wheel on a spindle
ES2394550T3 (es) 2008-02-21 2013-02-01 Sanofi Clorotiofen-amidas como inhibidores de los factores Xa de coagulación y trombina
WO2014174102A1 (en) * 2013-04-26 2014-10-30 Sanofi Tartrate salt of 5-chloro-thiophene-2-carboxylic acid [(s)-2-[methyl-3-(2-oxo-pyrrolidin-1-yl)-benzenesulfonylamino]-3-(4-methyl piperazin-1 -yl)-3-oxo-propryl]amide

Also Published As

Publication number Publication date
FI4396183T3 (fi) 2025-12-04
PE20240798A1 (es) 2024-04-18
HRP20251414T1 (hr) 2026-01-02
JOP20240043A1 (ar) 2024-02-29
CO2024002668A2 (es) 2024-03-07
SI4396183T1 (sl) 2026-01-30
KR20240055043A (ko) 2024-04-26
GEAP202416491A (en) 2024-05-10
ECSP24024658A (es) 2024-04-30
ES3055022T3 (en) 2026-02-09
US20230391761A1 (en) 2023-12-07
EP4396183B1 (en) 2025-09-03
MA66371B1 (fr) 2025-12-31
CR20240114A (es) 2024-05-22
US11912692B2 (en) 2024-02-27
PT4396183T (pt) 2025-11-25
WO2023031083A1 (en) 2023-03-09
JP7546172B2 (ja) 2024-09-05
TW202320754A (zh) 2023-06-01
GEP20257776B (en) 2025-06-25
PL4396183T3 (pl) 2026-02-09
US20250002483A1 (en) 2025-01-02
CL2024000638A1 (es) 2024-07-05
RS67431B1 (sr) 2025-12-31
ZA202402553B (en) 2025-09-25
AU2022338082A1 (en) 2024-02-15
EP4396183A1 (en) 2024-07-10
LT4396183T (lt) 2025-11-25
MX2024002750A (es) 2024-03-27
IL310777A (en) 2024-04-01
AR126980A1 (es) 2023-12-06
CA3230721A1 (en) 2023-03-09
DOP2024000024A (es) 2024-03-28
JP2024509511A (ja) 2024-03-04
CN117916236A (zh) 2024-04-19

Similar Documents

Publication Publication Date Title
EP4199925B1 (en) ORETIN RECEPTOR AGONISTS CYCLOPENTAPYRROLE
PT3958977T (pt) Derivados de camptotecina
IL292161A (en) New methylquinazolinone derivatives
EP4253377A4 (en) 5-HETEROARYL-1H-PYRAZOL-3-AMINE DERIVATIVE
EP4744661A2 (en) NEW PYRIMIDIN-2-YL SULFONAMIDE DERIVATIVES
PL4301748T3 (pl) Triazolilo-metylo podstawione pochodne alfa-d-galaktopiranozydu
EP4013751C0 (en) 2-HYDROXYCYCLOALKANE-1-CARBAMOYL DERIVATIVES
EP4400482A4 (en) GLASS BODY
EP4077334C0 (en) FUROINDAZOLE DERIVATIVES
EP4021904C0 (en) ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES
IL304774A (en) Enhanced sophorolipid derivatives
DK3823970T3 (da) Yderligere substituerede triazoloquinoxalinderivater
LT4396183T (lt) Pakeistieji s-alaninato dariniai
DK3823971T3 (da) Substituerede triazol-quinoxalin-derivater
EP4400483A4 (en) GLASS BODY
EP4308572C0 (en) NEW THIENOPYRIMIDINONE DERIVATIVES
EP4507692A4 (en) TRYPTAMINE DERIVATIVES
EP4308576C0 (en) NEW THIAZOLOPYRIMIDINONE DERIVATIVES
EP4137402A4 (en) MULTICOPTER
DK3894410T3 (da) Substituerede xanthinderivater
EP4166541A4 (en) Dimethylsulfoximine derivative
EP4320989A4 (en) MR-DC IMPROVEMENTS
EP4457227A4 (en) QUINOLEIN DERIVATIVE SUBSTITUTE
EP4361159A4 (en) Borono-phenylalanine derivative
EP4140985A4 (en) 2-HETEROARYLAMINOQUINAZOLINONE DERIVATIVE